Ridinilazole Uses, Dosage, Side Effects and more
Ridinilazole is under investigation in clinical trial NCT02092935 (A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)).
| Attribute | Details |
|---|---|
| Trade Name | Ridinilazole |
| Generic | Ridinilazole |
| Ridinilazole Other Names | Ridinilazole |
| Type | |
| Formula | C24H16N6 |
| Weight | Average: 388.434 Monoisotopic: 388.143644539 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
